Atreca to Present at Upcoming Investor Conferences
SAN CARLOS, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced that it will present at the following upcoming investor conferences:
H.C. Wainwright Global Investment Conference
Cowen’s 3rd Annual Oncology IO Next Summit
Jefferies Healthcare Conference
A live audio webcast of each presentation can be accessed through the Events & Presentations section of the Company's website at http://ir.atreca.com. An archived replay will be available on the Company's website for 30 days following each event.
About Atreca, Inc.
Source: Atreca, Inc.